woman smiling

Medication Safety Intensive

For a rapid infusion of knowledge in your institution

Three-times-a-year for more than a decade, practitioners from around country and outside of the U.S. gather to attend the highly-praised Medication Safety Intensive (MSI) workshop. This unique two-day program led by ISMP faculty and other selected medication safety experts is designed to help you substantially enhance your effectiveness in meeting today’s medication safety challenges.

Whether you are a pharmacist or nurse leader, a physician or dedicated safety officer, from an inpatient facility, or an outpatient setting, our faculty will challenge you to look at your organization through the eyes of the world’s leading safety experts and regulatory agencies, focusing efforts on medication-related issues that impact patient safety. You will engage in group discussions, participate in hands-on practice in error analysis and behavior identification, evaluate latent and active failures related to medication errors, learn how to effectively select high-leverage strategies, and use data to help sustain safety efforts within your organization.

Upon completion of the workshop, you will be armed with the specific knowledge and tools needed to be successful in establishing an aggressive, yet focused medication safety program and the associated infrastructure for continued safety improvements.

Won’t you join us?

Intended Audience:

Practitioners in acute care with responsibility for medication safety oversight including:

  • Medication Safety and Patient Safety Officers/Managers
  • Risk and Quality Improvement Professionals
  • Directors of Pharmacy and Nursing
  • Clinical Leads/Nurse Managers
  • Chief Medical Officers
  • Frontline clinical staff interested in medication safety
  • Pharmacy Residents

Learning Objectives:

Following completion of this workshop, participants will be able to:

  1. Perform system-based medication error analysis.
  2. Identify latent and active failures that lead to medication error events.
  3. Develop error-reduction strategies for the use of high-alert medications.
  4. Utilize various data collection methods to identify medication-related risk.
  5. Discuss the role and responsibilities of the medication safety officer or individual(s) responsible for medication safety oversight.
  6. Identify tools available to advance medication safety initiatives.
  7. Identify human error, at-risk behavior, and reckless behaviors from case studies.
  8. Describe appropriate organizational responses to human error and behavioral choices.
  9. Measure the effectiveness of selected error-reduction strategies.
  10. Network with other practitioners to problem solve challenging medication safety issues.

"The word 'intensive' truly defines the two days; I felt it translated into more than two years' worth of opportunities for growth and program development. The speakers' perspectives were founded in decades of practical experience but retained a forward-thinking mindset for innovation. This was a valuable and inspirational workshop."

-Jessica Kaczor, PharmD, BCPS

Upcoming Workshop Dates:


  • Day 1- 7:30 am - 4:30 pm

  • Day 2- 7:30 am - 2:30 pm


Each workshop will feature speakers drawn from our distinguished faculty:

  • Kelly Besco, PharmD, FISMP, CPPS
    Medication Safety Officer
    OhioHealth, Columbus, OH
  • Matthew Grissinger, RPh, FISMP, FASCP
    Director, Error Reporting Programs
    ISMP, Horsham, PA
  • Susan Paparella, MSN, RN
    Vice President
    ISMP, Horsham, PA
  • Elizabeth Wade, PharmD, BCPS
    Medication Safety Officer
    Concord Hospital, Concord, NH
  • Lorraineá Williams, PharmD
    Patient and Medication Safety Officer
    Cook Children’s Healthcare System, Fort Worth, TX


  • Early Registration: $1,025.00
    (up to 21 days before each program date)
  • Regular Registration: $1,195.00
    (20 days or less before each program date)

Contact ISMP

Looking for an advanced program? Consider the one-week Practitioner in Residence Mentorship

CE Accreditation

acpe logoEducational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmaceutical education. This program is approved for up to 12.5 hours (1.25 CEUs) of continuing pharmacy education. Statement of credit will be emailed within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit. This program has been assigned the Universal Program Number 0761-9999-19-130-L05-P,  0761-9999-19-130-L05-T. Educational Review Systems is also approved for pharmacy continuing education by the state of Florida. Nursing continuing education provider is approved by the California Board of Registered Nursing. This program has been assigned the Universal Program Number CEP 13677 and is approved for 12.5 contact hours (1.25 CEUs) of continuing nursing education.

Cancellations for the MSI must be received in writing by email, mail, or fax. Cancellations will be subject to a $100.00 processing fee for all cancellation requests received in writing at least 7 days prior to the start of the workshop. No refunds will be made after this time. If you plan to send someone else in your place, please notify ISMP prior to arrival.

In the unlikely event that ISMP must change the date or location of the program and a registrant is no longer able to attend as a result of the change, ISMP is responsible  only for a refund of the registration fee and is not responsible for any airfare, hotel, or other costs incurred by the registrant.